Provided by Tiger Trade Technology Pte. Ltd.

Goldman Sachs Future Health Care Equity ETF

37.35
-0.0885-0.24%
Post-market: 37.350.00000.00%16:10 EDT
Volume:57
Turnover:2K
Market Cap:19.61M
PE:- -
High:37.35
Open:37.44
Low:37.35
Close:37.44
52wk High:38.66
52wk Low:31.32
Shares:525.00K
Float Shares:525.00K
Volume Ratio:0.09
T/O Rate:0.01%
Dividend:0.11
Dividend Rate:0.30%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
19 mins ago

Johnson & Johnson Schedules Investor Call to Discuss Third-Quarter Results

Reuters
·
41 mins ago

Dow Jones Top Company Headlines at 5 PM ET: FTC Files Lawsuit Alleging Amazon Deceived Advertisers | State ...

Dow Jones
·
49 mins ago

Ataibeckley - Hart-Scott-Rodino Waiting Period for Merger with Eli Lilly Expired on Aug 28, 2026 - SEC Filing

THOMSON REUTERS
·
1 hour ago

NeuroThera Labs Advances Enrollment in Autism Drug Trial for SCI-210

TIPRANKS
·
1 hour ago

SciSparc subsidiary provides update on SCI-210 trial enrollment

TIPRANKS
·
1 hour ago

PMV Pharmaceuticals announces updated ovarian cancer data from PYNNACLE trial

TIPRANKS
·
1 hour ago

Kestra Medical Technologies to Report First Quarter Fiscal 2027 Financial Results on September 14

GlobeNewswire
·
1 hour ago

Press Release: Kestra Medical Technologies to Report First Quarter Fiscal 2027 Financial Results on September 14

Dow Jones
·
1 hour ago

Sector Update: Healthcare Stocks Decline Monday Afternoon

MT Newswires Live
·
4 hours ago

Moderately bullish activity in Eli Lilly with shares down 1.26%

TIPRANKS
·
5 hours ago

Top Midday Stories: Stocks Fall, Oil Rises Amid Renewed Fighting in Middle East; Utility Shares Fall After California Wildfire Legislation

MT Newswires Live
·
Yesterday

Protagonist Therapeutics' Own Pipeline Seen as Main Long-Term Growth Driver, Wedbush Says

MT Newswires Live
·
Yesterday

Dow Jones Top Company Headlines at 11 am ET: GameStop Sees Higher Profit as eBay Investment Offsets Lower Sales | SLB ...

Dow Jones
·
Yesterday

Lilly is Bigger than Ever. Why Its Latest $2.9 Billion Immunology Deal Makes Sense.

Dow Jones
·
Yesterday

Eli Lilly's Psoriasis Drug Trial Shows Sustained Positive Results

Dow Jones
·
Yesterday

Acotec Swings to Loss on R&D Surge and U.S. Trial Impairment

TIPRANKS
·
Yesterday

Lilly to Buy This Autoimmune Drugmaker for $2.9 Billion in Cash. What it Means for the Stock.

Dow Jones
·
Yesterday

Eli Lilly announces 52-week results from TOGETHER-PsO, TOGETHER-PsA

TIPRANKS
·
Yesterday

Eli Lilly - Taltz and Zepbound Lead to Deeper Improvements in Systemic Inflammation in Both Trials

THOMSON REUTERS
·
Yesterday